ALK Genomic Tumor Aberrations trials recruiting in New Hampshire

Fewer than 3 recruiting trials found.

All ALK Genomic Tumor Aberrations trials nationally

1

Recruiting in New Hampshire

1

Cities with sites

Cities in New Hampshire

Lebanon 1

Recruiting trials in New Hampshire

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
NCT06362369 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New Hampshire: Lebanon

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.